Cormorant Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-85,000	Closed	-$15.6M	–	71
2019 Q2	$15.6M	Buy	+85,000	New	+$15.6M	0.9%	31